Innovation defines the Brain Tumor Institute at Children’s National. Its experts have pioneered molecularly targeted therapies, vaccines, T-cell immunotherapies, and less invasive surgical techniques, reshaping how pediatric brain tumors are treated worldwide. Each year, the institute evaluates more than 100 new patients, delivering comprehensive care backed by leading-edge research. Children’s National is also recognized among the nation’s top hospitals for pediatric cancer. By combining discovery with compassionate care, Children’s National advances the shared mission of CBTN to accelerate breakthroughs and improve outcomes for every child facing a brain tumor.
Get the Latest
news, articles, and resources sent to your inbox.